Further benefits by early start of HIV treatment in low income countries: Survival estimates of early versus deferred antiretroviral therapy

BACKGROUND: International HIV guidelines have recently shifted from a medium-late to an early-start treatment strategy. As a consequence, more people will be eligible to Highly Active Antiretroviral Therapy (HAART). We estimate mean life years gained using different treatment indications in low inco...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Johansson, Kjell Arne, Robberstad, Bjarne, Norheim, Ole Frithjof
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2010
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2836271/
https://ncbi.nlm.nih.gov/pubmed/20180966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-6405-7-3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky